MedTrace Logo

Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill Parents

NCT02308462 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 400

Last updated 2020-07-20

No results posted yet for this study

Summary

In order to identify psychological stress in children and adolescents of mentally ill parents as early as possible, a special intervention program (CHIMPs = Children of mentally ill parents) was developed. The study at hand will implement this intervention program at five sites in Germany and will further evaluate its effectiveness. The CHIMPs intervention is assumed to reduce children's psychopathology and enhance their health related quality of life.

Conditions

  • Schizophrenia and Disorders With Psychotic Features
  • Mood Disorders
  • Neurotic Disorders
  • Personality Disorders
  • Substance-Related Disorders

Interventions

BEHAVIORAL

CHIMPS intervention

CHIMPs intervention (Family-Intervention composed of 8 Topic-related sessions over a period of 6 month, based on the evaluated manual: a preliminary talk with the family, two sessions with the parents, one session with each child, three sessions with the family). The sessions are semi-structured and cover the topics illness and coping, education, family relationships and trusting attachement figures, social network and support of the Family. A detailed description of the procedure is found in the Manual (Wiegand-Grefe, Halverscheid \& Plass, 2011).

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    collaborator OTHER

  • University of Ulm

    collaborator OTHER

  • Universitätsklinikum Leipzig

    collaborator OTHER

  • LWL-Klinikum Gütersloh

    collaborator UNKNOWN

  • Vitos Klinik Rheinhöhe

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    collaborator OTHER

  • Cantonal Hospital Winterthur, Switzerland

    collaborator UNKNOWN

  • Silke Wiegand-Grefe, Prof. Dr.

    lead OTHER

Principal Investigators

  • Silke Wiegand-Grefe, Prof. · Universitätsklinikum Hamburg-Eppendorf

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02308462 on ClinicalTrials.gov